Shuting Han
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Viral-associated cancers and disorders
- Cancer Cells and Metastasis
-
- Cancer-related molecular mechanisms research
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Treatments and Studies 3
- COVID-19 and healthcare impacts 3
- Viral-associated cancers and disorders 2
- Co-authors
- Xian Wang (4 shared papers)Hongchuan Jin (4 shared papers)Yiran Zhu (2 shared papers)Ping Song (2 shared papers)Miaoqin Chen (2 shared papers)Lifeng Feng (2 shared papers)Liyuan Zhu (2 shared papers)Dongjun Dai (3 shared papers)
In The Last Decade
Shuting Han
23 papers receiving 834 citations
Shuting Han's Hit Papers
Peers
Comparison fields: 5 of 65
- Oncology 295
- Cancer Research 109
- Otorhinolaryngology 41
- Molecular Biology 293
- Pathology and Forensic Medicine 43
Countries citing papers authored by Shuting Han
This map shows the geographic impact of Shuting Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuting Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuting Han more than expected).
Fields of papers citing papers by Shuting Han
This network shows the impact of papers produced by Shuting Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuting Han. The network helps show where Shuting Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuting Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer Hit paper breakdown → | 2022 | 270 |
| 2 | 2019 | 160 | |
| 3 | 2021 | 80 | |
| 4 | 2021 | 52 | |
| 5 | 2021 | 47 | |
| 6 | 2022 | 39 | |
| 7 | 2020 | 24 | |
| 8 | Anemia is associated with poor outcomes of metastatic castration-resistant prostate cancer, a systematic review and meta-analysis. | 2018 | 21 |
| 9 | 2025 | 21 | |
| 10 | 2020 | 20 | |
| 11 | 2023 | 18 | |
| 12 | 2019 | 14 | |
| 13 | 2020 | 14 | |
| 14 | 2020 | 13 | |
| 15 | 2022 | 12 | |
| 16 | 2022 | 11 | |
| 17 | 2020 | 7 | |
| 18 | 2025 | 7 | |
| 19 | 2019 | 4 | |
| 20 | 2024 | 3 |
About Shuting Han
Shuting Han is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Otorhinolaryngology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 28 papers that have together received 841 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Colorectal Cancer Treatments and Studies (3 papers), COVID-19 and healthcare impacts (3 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers), Genetic factors in colorectal cancer (2 papers), Salivary Gland Disorders and Functions (2 papers), Head and Neck Cancer Studies (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Oncology (295 citations), Cancer Research (109 citations), Otorhinolaryngology (41 citations), Molecular Biology (293 citations) and Pathology and Forensic Medicine (43 citations). Shuting Han has collaborated with scholars based in Singapore, China and Germany. Frequent co-authors include Xian Wang, Hongchuan Jin, Yiran Zhu, Ping Song, Miaoqin Chen, Lifeng Feng, Liyuan Zhu, Dongjun Dai, Han Chong Toh and Vivian Yvonne Shin. Their work appears in journals such as Science Advances, The Lancet. Gastroenterology & hepatology, Nature Communications, ESMO Open and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.